Understand the source comparison
Mechanism-of-Action Differences: Hypothalamic vs Pituitary vs Gonadal Targets
Kisspeptin-10 operates at the hypothalamic level by binding GPR54 (KISS1R) receptors on GnRH neurons, triggering calcium influx and depolarization that releases endogenous GnRH in physiological pulse patterns. Typically 90-minute intervals in males, variable i
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Kisspeptin-10 operates at the hypothalamic level by binding GPR54 (KISS1R) receptors on GnRH neurons, triggering calcium influx and depolarization that releases endogenous GnRH in physiological pulse patterns. Typically 90-minute intervals in males, variable in females based on menstrual cycle phase. The downstream effect is pulsatile LH and FSH secretion from the anterior pituitary, which then stimulates gonadal steroidogenesis and gametogenesis. This preserved pulsatility matters: continuous GnRH exposure (as with long-acting analogs) desensitizes GnRH receptors on gonadotrophs within 7–10 days, producing iatrogenic hypogonadism. The exact opposite of the intended outcome.
- GnRH analogs like Triptorelin and Leuprolide bypass the hypothalamus entirely, binding directly to pituitary GnRH receptors with 50–100× higher affinity than endogenous GnRH. Initial administration produces a "flare" effect. LH and FSH surge for 48–72 hours as all available gonadotrophs discharge their hormone stores simultaneously. After this flare, continuous receptor occupancy triggers downregulation: GnRH receptor expression drops by 80–90%, gonadotropin synthesis halts, and circulating LH/FSH fall to castration levels. This paradoxical suppression is exploited therapeutically in conditions like prostate cancer or endometriosis, but it's catastrophic if your research model requires sustained gonadotropin output.
- HCG mimics LH action at the gonadal level by binding the shared LH/CG receptor on Leydig cells (testes) or theca cells (ovaries). Unlike endogenous LH (half-life 20–30 minutes), HCG has a half-life of 24–36 hours due to heavily glycosylated beta-subunit structure that resists renal clearance. This extended half-life produces sustained intracellular cAMP elevation and prolonged steroidogenic enzyme activation. Testosterone synthesis in males, progesterone and estradiol in females. The trade-off: HCG doesn't replicate pulsatile LH signaling, so chronic administration can desensitize LH receptors and suppress endogenous LH secretion through negative feedback.